| JXSL2500054 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2025-04-08 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2500045 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2025-03-26 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2400231 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-11-28 | | Daiichi Sankyo Co Ltd | | | view |
| JXSL2400171 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-09-15 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2400117 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2024-06-27 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2300232 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-12-22 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2300173 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-10-09 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2300051 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2023-03-14 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200174 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-30 | | AstraZeneca AB;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200166 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-16 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2200156 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-09-08 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSL2200072 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2022-06-03 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101147 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-12-14 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101124 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-11-09 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101122 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-11-01 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSL2101101 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-08-24 | | Daiichi Sankyo Co Ltd;Astrazeneca Investment (China) Co Ltd | | | view |
| JXSL2101081 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Import Drug Application | 2021-07-29 | | First Pharmaceutical (China) Co Ltd;Daiichi Sankyo Co Ltd | | | view |
| JXSB2500041 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2025-05-17 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
| JXSB2400181 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-12-28 | | AstraZeneca AB;Baxter Oncology GmbH | | | view |
| JXSB2400090 | DS-1062a | datopotamab deruxtecan | Injection | Biological Products(1) | Supplementary Application | 2024-07-05 | | Daiichi Sankyo Co Ltd;Baxter Oncology GmbH | | | view |
